Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation. Read why I rate CL stock a Buy right now.
Colgate-Palmolive: A Defensive Staple With Meaningful Upside (NYSE:CL)

60
Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation. Read why I rate CL stock a Buy right now.